BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30041953)

  • 21. Evaluation and correlation of mammographically suspicious lesions with histopathology at Addington Hospital, Durban.
    Cupido BD; Vawda F; Sabri A; Sikwila CT
    S Afr Med J; 2013 Mar; 103(4):251-4. PubMed ID: 23547702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Added value of contrast-enhanced mammography in assessment of breast asymmetries.
    Wessam R; Gomaa MMM; Fouad MA; Mokhtar SM; Tohamey YM
    Br J Radiol; 2019 Jun; 92(1098):20180245. PubMed ID: 30932687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting.
    Tennant SL; James JJ; Cornford EJ; Chen Y; Burrell HC; Hamilton LJ; Girio-Fragkoulakis C
    Clin Radiol; 2016 Nov; 71(11):1148-55. PubMed ID: 27296475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
    Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
    Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
    Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
    Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion.
    Patel BK; Naylor ME; Kosiorek HE; Lopez-Alvarez YM; Miller AM; Pizzitola VJ; Pockaj BA
    Clin Imaging; 2017; 46():44-52. PubMed ID: 28723585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
    Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
    Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study.
    Lobbes MBI; Mulder HKP; Rousch M; Backes WH; Wildberger JE; Jeukens CRLPN
    Eur J Radiol; 2018 Sep; 106():114-121. PubMed ID: 30150032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
    Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
    Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
    Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
    Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Targeted Ultrasound to Predict Malignancy Among Lesions Detected on Contrast-Enhanced Digital Mammography.
    Coffey K; Sung J; Comstock C; Askin G; Jochelson MS; Morris EA; D'Alessio D
    AJR Am J Roentgenol; 2021 Sep; 217(3):595-604. PubMed ID: 33025811
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis.
    Cheung YC; Tsai HP; Lo YF; Ueng SH; Huang PC; Chen SC
    Eur Radiol; 2016 Apr; 26(4):1082-9. PubMed ID: 26159872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Frozen Section in Patients with Non-Palpable Breast Lesions.
    Abuoglu HH; Günay E; Sunamak O; Yiğitbaşı MR;
    Chirurgia (Bucur); 2016; 111(6):500-504. PubMed ID: 28044952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Dong H; Huang Y; Song F; Dai H; Liu P; Zhu Y; Wang P; Han J; Hao X; Chen K
    Clin Breast Cancer; 2018 Jun; 18(3):e353-e361. PubMed ID: 28887010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrical impedance scanning in the differentiation of suspicious breast lesions: comparison with mammography, ultrasound and histopathology].
    Fuchsjäger MH; Helbich TH; Ringl H; Funovics MA; Rudas M; Riedl C; Pfarl G
    Rofo; 2002 Dec; 174(12):1522-9. PubMed ID: 12471524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Assessment of Contrast Enhancement on Contrast Enhancement Spectral Mammography (CESM) and Comparison With Qualitative Assessment.
    Rudnicki W; Heinze S; Popiela T; Kojs Z; Luczynska E
    Anticancer Res; 2020 May; 40(5):2925-2932. PubMed ID: 32366444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D quantitative breast ultrasound analysis for differentiating fibroadenomas and carcinomas smaller than 1cm.
    Meel-van den Abeelen AS; Weijers G; van Zelst JC; Thijssen JM; Mann RM; de Korte CL
    Eur J Radiol; 2017 Mar; 88():141-147. PubMed ID: 28189199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.